Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$10K Sell
163
-2,229
-93% -$135K 0.49% 50
2016
Q4
$134K Buy
2,392
+169
+8% +$9.89K 0.64% 40
2016
Q3
$132K Sell
2,223
-1,055
-32% -$61.7K 0.65% 35
2016
Q2
$180K Buy
3,278
+566
+21% +$30.1K 0.87% 29
2016
Q1
$137K Buy
2,712
+4
+0.1% +$196 0.59% 43
2015
Q4
$136K Sell
2,708
-288
-10% -$14.5K 0.58% 53
2015
Q3
$141K Buy
2,996
+806
+37% +$42.8K 0.63% 46
2015
Q2
$119K Sell
2,190
-2,082
-49% -$117K 0.49% 71
2015
Q1
$234K Sell
4,272
-1,806
-30% -$102K 0.93% 26
2014
Q4
$329K Buy
6,078
+39
+0.6% +$2.17K 1.3% 11
2014
Q3
$342K Buy
6,039
+11
+0.2% +$618 1.41% 13
2014
Q2
$333K Buy
6,028
+162
+3% +$8.84K 1.4% 11
2014
Q1
$318K Buy
5,866
+79
+1% +$4.09K 1.41% 12
2013
Q4
$276K Buy
5,787
+3,562
+160% +$163K 1.26% 16
2013
Q3
$101K Sell
2,225
-318
-13% -$14.5K 0.51% 73
2013
Q2
$113K Buy
+2,543
New +$114K 0.52% 64

Other funds holding MRK

New York Life Trust's MRK Position: Q1 2017 in Review

New York Life Trust reduced its Merck (MRK) stake by 93% in Q1 2017, selling an estimated $135K and leaving 163 shares worth $10K. The position accounts for 0.49% of the portfolio, ranked #50.

New York Life Trust first reported a position in MRK in Q2 2013 and has held it in 16 quarters since. The position peaked at $342K in Q3 2014. 1,942 funds tracked by Wall St. Rank hold MRK as of Q1 2017.

  • New York Life Trust held 163 shares of Merck worth $10K as of Q1 2017.
  • New York Life Trust sold 2,229 Merck shares in Q1 2017, an estimated $135K.
  • Merck made up 0.49% of New York Life Trust's portfolio in Q1 2017, its #50 holding.
  • New York Life Trust first reported a position in Merck in Q2 2013 and has held it in 16 quarters since.
  • New York Life Trust's Merck position peaked at $342K in Q3 2014.
  • 1,942 funds tracked by Wall St. Rank held Merck as of Q1 2017.

Based on New York Life Trust's 13F filing for Q1 2017, filed 12 May 2017.